19 May 2013
Keywords: roche, tamiflu, reduces, death, risk, seasonal, flu
Article | 09 October 2006
Swiss drug major Roche says that its key antiviral Tamiflu (oseltamivir) is effective in reducing the risk of death associated ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 October 2006
27 November 2006
17 May 2013
© 2013 thepharmaletter.com